Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines. - Wikidata - wikimedia - TriplyDB

Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.

Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.

http://www.wikidata.org/entity/Q37578604

about

E2F8 is a Potential Therapeutic Target for Hepatocellular Carcinoma Can TIE-2 expressing monocytes represent a novel marker for hepatocellular carcinoma?The Spectrum of E2F in Liver Disease--Mediated Regulation in Biology and Cancer.miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer.Positioning of proteasome inhibitors in therapy of solid malignancies.E2F is involved in radioresistance of carbon ion induced apoptosis via Bax/caspase 3 signal pathway in human hepatoma cell.Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.

P2860

Q33776715-9F836AD8-637F-4C24-A864-225E806F6ACC Q34077177-B32AA0C6-388D-4555-A9C8-C530FEAF55B6 Q38633009-EF9644B3-569D-42F2-95A4-785004730B55 Q45992649-9843B8AB-D21A-448A-86F7-F00E5EB2FB96 Q47353792-738D846A-1C29-4BA9-B360-4F2ED59CA833 Q48149214-2E52262D-528B-4CBB-9D93-023BFF862699 Q52586706-A77F0B3B-3E52-4CE5-AED5-C861276103A6

P2860

Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.

http://www.wikidata.org/entity/Q37578604

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Bortezomib effect on E2F and c ...... cellular carcinoma cell lines.

@en

Bortezomib effect on E2F and c ...... cellular carcinoma cell lines.

@nl

type

label

Bortezomib effect on E2F and c ...... cellular carcinoma cell lines.

@en

Bortezomib effect on E2F and c ...... cellular carcinoma cell lines.

@nl

prefLabel

Bortezomib effect on E2F and c ...... cellular carcinoma cell lines.

@en

Bortezomib effect on E2F and c ...... cellular carcinoma cell lines.

@nl

P1433

Q37578604-BB62BF8C-1C7E-430A-8F2F-E34FD8D5C738

P1476

Q37578604-DB08D88C-188E-49EC-954D-83997CE7A7E0

P2093

Q37578604-00B8A730-A4EF-46D7-8DCC-A1AFE2B6B4F3

Q37578604-11EF5FD2-506D-4F18-9DDD-9D1A4932E00C

Q37578604-2BE7100C-0E89-4F5F-9637-F9A502B059F0

Q37578604-3449E95A-886C-450A-84A7-DD86ABACDB6B

Q37578604-3E1CAECC-8B1F-434F-B45E-45353B640A55

Q37578604-6E5FE4EC-CD79-4929-9ED7-20DAE5C8BF83

Q37578604-769F7542-1D8C-4DFF-9AC6-27E87697D43E

Q37578604-FBCFFAE1-7619-4B33-92C1-48F6B156F1A6

P2860

Q37578604-17CC228D-DCB0-40C3-B1F8-3E5073A6ABA5

Q37578604-28E04460-B746-497C-8F2C-025ED3668E2C

Q37578604-2ECDE277-B53F-41C0-B9F1-EE7DCD341817

Q37578604-3800B93E-67F6-43A6-8E89-4B4C76E119D8

Q37578604-3C801CCD-771B-4BB0-8330-96D1868ACD55

Q37578604-3F67AA9C-EEBA-4C5A-AA1D-5BB7545188F0

Q37578604-49618BE5-6435-4564-8ABA-59502297D7EB

Q37578604-4CBFC741-37E0-4C57-AAD2-0CD0E9541356

Q37578604-52AB8CF5-AA2A-4F0A-90A1-19E600E2C3B4

Q37578604-581705AB-8CAB-473C-B69E-2867CCCB0B42

P304

Q37578604-6192557E-CCDE-4D53-80F5-3AE34B872F24

P31

Q37578604-6FC873D8-04DB-4E16-9012-EBED0DF12C90

P356

Q37578604-47335E7D-B25E-446B-A4A1-8D76254650C0

P407

Q37578604-C12D4546-5916-4E38-AF92-988C388C1EC0

P433

Q37578604-6A2C4988-96C4-4C3E-BF47-DEF7C872177B

P478

Q37578604-6ECABC11-9C6F-4488-AA10-1A0F13265E88

P50

Q37578604-B21B07FF-87EA-41D5-A3AA-65CD809B0AC6

Q37578604-C11C0B28-515A-4536-B42A-29202DBA19EA

P577

Q37578604-9ECD501E-98AD-4620-B837-BA764F044C8F

P5875

Q37578604-AD5D1530-E261-4EA2-B446-348945BC69DB

P698

Q37578604-97D34FCE-CE13-479C-8F0B-8F3E31D8250B

P932

Q37578604-4EE9CCEE-8039-40D8-B233-4B1A19634B17

P356

P1433

World Journal of Gastroenterology

P1476

Bortezomib effect on E2F and c ...... cellular carcinoma cell lines.

@en

P2093

Barbara Dapas

http://www.w3.org/2001/XMLSchema#string

Bruna Scaggiante

http://www.w3.org/2001/XMLSchema#string

Daniele Baiz

http://www.w3.org/2001/XMLSchema#string

Gabriele Pozzato

http://www.w3.org/2001/XMLSchema#string

Lara Consoloni

http://www.w3.org/2001/XMLSchema#string

Nicola Fiotti

http://www.w3.org/2001/XMLSchema#string

Rossella Farra

http://www.w3.org/2001/XMLSchema#string

Sara Chiaretti

http://www.w3.org/2001/XMLSchema#string

P2860

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Hepatocellular carcinoma

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma.

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome.

The E2F family: specific functions and overlapping interests

The changing pattern of epidemiology in hepatocellular carcinoma.

P304

795-803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I3.795

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Fabrizio Zanconati

Gabriele Grassi

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260396972

http://www.w3.org/2001/XMLSchema#string

P698

24574752

http://www.w3.org/2001/XMLSchema#string

P932

3921488

http://www.w3.org/2001/XMLSchema#string